港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

1,308.644

+15.1701.17%

涨家数：9

跌家数：2

平家数：2

市盈率：- -

高：1,314.756

开：1,294.988

低：1,282.421

收：1,293.473

成交量：1.02亿

成交额：13.06亿

市值：2,178.87亿

流通市值：1,582.36亿

数据加载中...

复星医药现金流压力下创新药豪赌 12.56亿元出售资产难填96亿元窟窿？

复星医药（600196）披露执行董事候选人议案，9月30日股价上涨1.63%

康哲药业(00867)获得1类新药MG-K10人源化单抗注射液新增慢性阻塞性肺疾病适应症药物临床试验批准通知书

全球化布局持续深化复星医药中东办公室于沙特吉达正式揭牌

“一页纸”吃透产业链之：创新药，License-out BD进军全球市场

复星医药：吴以芳辞任非执行董事周旭东辞任高级副总裁

锐正基因完成7500万美元A轮融资携手西藏药业与康哲药业开启战略合作

复星医药：控股子公司药品获临床试验批准

三生制药：2025 中期报告

香港交易所

复星医药(02196)建议委任刘毅为执行董事

四环医药(00460)旗下渼颜空间自主研发的含L-肌肽的复合溶液水光针“冻妍”获国家药监局批准上市

每日卖空追踪 | 康哲药业 09月30日卖空量成交42万股，卖空比例为4.69%

康哲药业09月30日主力净流入499.5万元散户资金抛售

昊海生物科技09月30日获主力加仓168.6万元

四环医药(00460)出现大手卖出120万股，成交价$1.61，涉资193.2万

阿斯达克财经

招银国际：美国针对创新药将加征关税预期对CXO影响有限推荐买入三生制药(01530)等

诺华眼科撤出中国传言再起，一个时代终结了

复星医药徐汇宜山路项目12.56亿元易主！

昊海生物科技(06826)：楼国梁已累计减持公司股份149.14万股

每日卖空追踪 | 复星医药 09月29日卖空量成交12.65万股，卖空比例为2.39%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1593/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1308.6436,"timestamp":1759219682091,"preClose":1293.4733,"halted":0,"volume":101712892,"delay":0,"changeRate":0.011728,"floatShares":0,"shares":0,"eps":0,"marketStatus":"国庆日休市","change":15.170288,"latestTime":"09-30 16:00:00","open":1294.9884,"high":1314.7557,"low":1282.4209,"amount":1306486169,"amplitude":0.024998,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759368600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1759195800000,1759204800000],[1759208400000,1759219200000]],"pbRate":1.904861,"peRate":26.7728,"turnoverRate":0.004924,"increases":8,"decrements":3,"flats":2,"marketCap":217887394200,"floatMarketCap":158236398872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":1314.7557,"amplitude":0.024998,"preClose":1293.4733,"low":1282.4209,"pbRate":"1.904861","latestPrice":1308.6436,"volume":101712892,"delay":0,"open":1294.9884,"prevYearClose":571.87146,"prevWeekClose":1276.55,"prevMonthClose":1308.644,"prevQuarterClose":1308.644,"fiveDayClose":1356.006,"twentyDayClose":1314.432,"sixtyDayClose":1056.714,"secType":"PLATE","market":"HK","turnoverRate":0.004924,"peRate":26.7728,"marketCap":217887394200,"floatMarketCap":158236398872,"timestamp":1759219682091,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":9,"down":2,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2572302516","title":"复星医药现金流压力下创新药豪赌 12.56亿元出售资产难填96亿元窟窿？","url":"https://stock-news.laohu8.com/highlight/detail?id=2572302516","media":"华夏时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572302516?lang=zh_cn&edition=fundamental","pubTime":"2025-10-01 11:02","pubTimestamp":1759287751,"startTime":"0","endTime":"0","summary":"【复星医药现金流压力下创新药豪赌 12.56亿元出售资产难填96亿元窟窿？】9月26日，复星医药发布公告称，公司控股子公司复星医药产业拟筹划转让上海克隆100%股权，交易对价不超过12.56亿元。这已是复星医药今年来又一笔资产处置。截至2025年上半年，公司已签约处置项目总额超20亿元，这一切都指向了同一个目标——补充现金流，为创新药转型续航。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510013527988446.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510013527988446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02196","BK1574","BK1191","06978","BK1515","BK1161","BK1593"],"gpt_icon":0},{"id":"2572530962","title":"复星医药（600196）披露执行董事候选人议案，9月30日股价上涨1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572530962","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572530962?lang=zh_cn&edition=fundamental","pubTime":"2025-10-01 09:10","pubTimestamp":1759281002,"startTime":"0","endTime":"0","summary":"近日，上海复星医药(集团)股份有限公司发布第十届董事会第十一次会议决议公告。公告显示，因个人工作变动，吴以芳辞去公司非执行董事职务，辞任自2025年9月30日生效。董事会审议通过关于执行董事候选人的议案，提名刘毅为执行董事候选人，提交股东会选举。表决结果为同意11票，反对0票，弃权0票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251001/31686811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0060","BK0028","BK0187","BK0188","BK1593","BK1515","BK0012","BK0183","BK0175","BK1191","BK0196","600196","BK0239","BK0096","02196"],"gpt_icon":0},{"id":"2571347026","title":"康哲药业(00867)获得1类新药MG-K10人源化单抗注射液新增慢性阻塞性肺疾病适应症药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2571347026","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571347026?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 20:37","pubTimestamp":1759235825,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)公布，集团拥有共同开发权(除特应性皮炎(AD)外)及独家商业化权利的1类新药抗IL-4Rα MG-K10人源化单抗注射液(MG-K10)于2025年9月29日获中国国家药品监督管理局(NMPA)签发的药物临床试验批准通知书， NMPA同意开展MG-K10用于慢性阻塞性肺疾病(COPD)的临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B66KJ199.SGD","00867","BK4123","LU2488822045.USD","IE00BYV24P56.USD","IE00B19Z4B17.USD","SG9999015952.SGD","SG9999015945.SGD","IE00BVYPNQ40.USD","SG9999015986.USD","MG","BK1593","IE00B7SZL793.SGD","IE00BMCWC346.EUR","BK1191","SG9999015978.USD","IE00BVYPNP33.GBP","SG9999004220.SGD","IE00BGHQDM52.EUR","IE0031619046.USD"],"gpt_icon":0},{"id":"2572300832","title":"全球化布局持续深化 复星医药中东办公室于沙特吉达正式揭牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2572300832","media":"复星医药","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572300832?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 20:32","pubTimestamp":1759235550,"startTime":"0","endTime":"0","summary":"9月29日，复星医药中东办公室暨Fosunhenlius Middle East United Company揭牌仪式在沙特阿拉伯吉达隆重举行。此举标志着复星医药在中东地区的本土化运营迈出重要一步，也是公司以创新为引擎，持续深化全球化布局的战略举措。复星医药致力于通过全球研发与商业化网络，为患者提供高品质创新药物。Fosunhenlius Middle East United Company是由沙特领先的生物制药企业SVax与复星医药旗下国际化的创新生物制药公司复宏汉霖共同组建的合资企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220528a6a894f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220528a6a894f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02196","BK1191","BK1593"],"gpt_icon":0},{"id":"2572379245","title":"“一页纸”吃透产业链之：创新药，License-out BD进军全球市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2572379245","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572379245?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 19:31","pubTimestamp":1759231872,"startTime":"0","endTime":"0","summary":"创新药行业规模与特征创新药是相对于仿制药的概念，指拥有自主知识产权专利、在全球范围内首次获批上市的全新药物。创新药通过经销商、配送商等流通渠道，最终到达医院、药店等终端机构。药物获批上市后，仍需进行IV期临床试验，以持续监测药物在广泛人群中使用的长期安全性与有效性。对外授权已成为核心增长引擎和关键“造血”来源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930193524a6a85acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930193524a6a85acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","06978","BK1161","01530","ONC","BK1593"],"gpt_icon":0},{"id":"2572070013","title":"复星医药：吴以芳辞任非执行董事 周旭东辞任高级副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2572070013","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572070013?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 18:36","pubTimestamp":1759228560,"startTime":"0","endTime":"0","summary":"复星医药(02196)发布公告，2025年9月30日，本公司董事会分别收到吴以芳先...复星医药(02196)发布公告，2025年9月30日，本公司董事会分别收到吴以芳先生、周旭东先生的书面辞职函，具体如下：一、因个人工作变动，吴以芳先生向董事会申请辞去非执行董事职务。根据《上海复星医药(集团)股份有限公司章程》(以下简称“《公司章程》”)规定，吴以芳先生的辞任于送达董事会时生效。二、因个人发展原因，周旭东先生向董事会申请辞去高级副总裁职务。周旭东先生自2025年9月30日起不再担任本公司高级副总裁职务。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930183907954e1bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930183907954e1bef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02196","BK1191","BK1515"],"gpt_icon":0},{"id":"2572377280","title":"锐正基因完成7500万美元A轮融资 携手西藏药业与康哲药业开启战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2572377280","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572377280?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 17:49","pubTimestamp":1759225743,"startTime":"0","endTime":"0","summary":"锐正基因近日顺利完成总额达7500万美元的A轮融资，并与本轮投资方西藏药业、康哲药业达成全面战略合作。此次合作将显著提升锐正基因在研发创新、产业转化及商业运营方面的综合实力，为基因治疗领域的技术突破与产品管线价值释放注入新动能。多方协同将加速推动前沿基因技术从实验室走向临床应用，为患者提供更先进的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930175123954e09cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930175123954e09cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","IE00BGHQDM52.EUR","SG9999015952.SGD","IE00BVYPNQ40.USD","SG9999015945.SGD","IE00BVYPNP33.GBP","SG9999004220.SGD","00867","IE00BMCWC346.EUR","BK1593","LU2488822045.USD","IE00BYV24P56.USD","SG9999015978.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"2571831093","title":"复星医药：控股子公司药品获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2571831093","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571831093?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 17:01","pubTimestamp":1759222880,"startTime":"0","endTime":"0","summary":"【复星医药：控股子公司药品获临床试验批准】复星医药(600196)9月30日公告，控股子公司复宏汉霖收到国家药品监督管理局关于同意注射用HLX43联合HLX07治疗晚期/转移性实体瘤开展临床试验的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509303527479112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK1515","02196","BK1191"],"gpt_icon":0},{"id":"2572379271","title":"三生制药：2025 中期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2572379271","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572379271?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 17:00","pubTimestamp":1759222821,"startTime":"0","endTime":"0","summary":"牛牛AI助手已提取核心信息三生制药公布2025年上半年业绩。此外，707注射液获国家药监局纳入突破性治疗品种，适应症为一线治疗PD-L1表达...展开全部三生制药公布2025年上半年业绩。三生制药公布2025年上半年业绩。目前积极研发30项重点产品，其中27项于中国内地作为创新药物开发，包括18项抗体药物、6项其他生物制品及6项小分子药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930173235a6a822ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930173235a6a822ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","01530","BK1583","BK1161"],"gpt_icon":0},{"id":"2571892317","title":"复星医药(02196)建议委任刘毅为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2571892317","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571892317?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 16:43","pubTimestamp":1759221807,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，(1)吴以芳先生因个人工作变动辞任非执行董事，自2025年9月30日起生效;及(2)建议委任刘毅先生为第十届董事会执行董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK1191","BK0096","BK1593","BK0239","BK0183","BK1515","600196","BK0028","BK0187","BK0188","BK0196","02196","BK0060","BK0175"],"gpt_icon":0},{"id":"2571312697","title":"四环医药(00460)旗下渼颜空间自主研发的含L-肌肽的复合溶液水光针“冻妍”获国家药监局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2571312697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571312697?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 16:34","pubTimestamp":1759221257,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 发布公告，集团旗下渼颜空间生物科技(吉林)有限公司自主研发的注射用透明质酸钠复合溶液正式获得中国国家药品监督管理局颁发第三类医疗器械注册证。渼颜空间自主研发的“冻妍”-注射用透明质酸钠复合溶液水光针，基于皮肤生理特点设计，是一款可直接用于面部、旨在暂时改善皮肤干燥及肤色暗沉的水光针产品。该产品须由医疗机构专业人员经面部真皮层注射使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","00460","BK1600","BK1191","BK1515"],"gpt_icon":0},{"id":"2572377405","title":"每日卖空追踪 | 康哲药业 09月30日卖空量成交42万股，卖空比例为4.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572377405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572377405?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 16:30","pubTimestamp":1759221016,"startTime":"0","endTime":"0","summary":"康哲药业北京时间09月30日，涨1.75%，卖空量成交42万股，较上一交易日减少30.46%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930163131a6a80305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930163131a6a80305&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BVYPNP33.GBP","SG9999015986.USD","LU2488822045.USD","SG9999015952.SGD","00867","IE00BGHQDM52.EUR","SG9999015945.SGD","IE00BVYPNQ40.USD","BK1191","IE00BYV24P56.USD","SG9999004220.SGD","BK1593","IE00BMCWC346.EUR","SG9999015978.USD"],"gpt_icon":0},{"id":"2572377403","title":"康哲药业09月30日主力净流入499.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2572377403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572377403?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 16:16","pubTimestamp":1759220168,"startTime":"0","endTime":"0","summary":"09月30日, 康哲药业股价涨1.75%，报收13.99元，成交金额1.2亿元，换手率0.37%，振幅3.56%，量比1.33。康哲药业今日主力资金净流入499.5万元，上一交易日主力净流出810.4万元。该股近5个交易日下跌6.70%，主力资金累计净流出211.1万元；近20日主力资金累计净流入4121.5万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930162412a44e2182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930162412a44e2182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","IE00BGHQDM52.EUR","SG9999015952.SGD","IE00BVYPNQ40.USD","SG9999015945.SGD","IE00BVYPNP33.GBP","SG9999004220.SGD","00867","IE00BMCWC346.EUR","BK1593","LU2488822045.USD","IE00BYV24P56.USD","SG9999015978.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"2572375685","title":"昊海生物科技09月30日获主力加仓168.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572375685","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572375685?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 16:15","pubTimestamp":1759220159,"startTime":"0","endTime":"0","summary":"09月30日, 昊海生物科技股价涨2.21%，报收26.86元，成交金额749.2万元，换手率0.73%，振幅3.04%，量比0.92。昊海生物科技今日主力资金净流入168.6万元，连续4日净流入，上一交易日主力净流入152.6万元。该股近5个交易日下跌0.15%，主力资金累计净流入358.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入262.5万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301623519719f8de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301623519719f8de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06826","BK1593","BK1161"],"gpt_icon":0},{"id":"2571134234","title":"四环医药(00460)出现大手卖出120万股，成交价$1.61，涉资193.2万","url":"https://stock-news.laohu8.com/highlight/detail?id=2571134234","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571134234?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 16:08","pubTimestamp":1759219680,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在下午04:08出现大手卖出，成交量为120万，成交价为港币$1.61，涉资193.2万。至目前为止，股价升5.921%，今日最高价为$1.62，而最低价为$1.51，总成交量为5.428千万股，总成交金额港币$8.524千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2509308918/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1593","BK1600","BK1515","00460","BK1191"],"gpt_icon":0},{"id":"2571142633","title":"招银国际：美国针对创新药将加征关税预期对CXO影响有限 推荐买入三生制药(01530)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2571142633","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571142633?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 15:56","pubTimestamp":1759219015,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，预期中美创新合作将持续，中国国内创新研发需求回暖。叠加美国降息，CXO 行业有望在下半年迎来业绩修复。而美国针对创新药将加征关税，预期对CXO影响有限。特朗普于9月25日宣布，除非制药商正在美国建设工厂，否则从10月1日开始，专利药品将面临100%的关税。由于多家跨国药企已有美国建厂计划，因此或将不受影响。推荐买入三生制药、巨子生物、药明合联、固生堂、中国生物制药、信达生物 。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","159992","BK1161","LU0455707207.USD","06978","LU2097828557.USD","BK1515","LU2097828805.USD","SG9999004311.SGD","BK1589","IE00BZ08YR35.GBP","BK1207","BK1593","IE00BZ08YT58.USD","LU2097828631.EUR","02273","BK1191","LU2328871848.SGD","01177","01530","BK1583","BK1141","IE00BZ08YS42.EUR","LU2488822045.USD","CXO","BK1219","LU1969619763.USD","SG9999014674.SGD","LU2097828714.EUR","LU0502904849.HKD","BK1521","LU2242644610.SGD","BK1574","01801","02367","LU2097828474.EUR"],"gpt_icon":0},{"id":"2571361284","title":"诺华眼科撤出中国传言再起，一个时代终结了","url":"https://stock-news.laohu8.com/highlight/detail?id=2571361284","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571361284?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 21:11","pubTimestamp":1759151464,"startTime":"0","endTime":"0","summary":"近日，诺华眼科撤出中国的流言再起，9月29日，有业内人士告诉健识局，基本已经确定由康哲药业接手诺华眼底疾病产品，目前一线城市康哲药业的医药代表已经开始拜访诺华雷珠单抗、布西珠单抗两款产品的客户了。到了2023年12月，罗氏的双抗新药法瑞西单抗、齐鲁的阿柏西普生物类似药同一天获批，诺华中国眼科在中国的堡垒进一步崩塌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092921270197b10850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092921270197b10850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BVYPNQ40.USD","BK1191","BK1593","SG9999015952.SGD","SG9999015945.SGD","LU2488822045.USD","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","IE00BYV24P56.USD","SG9999015986.USD","SG9999015978.USD","IE00BGHQDM52.EUR","SG9999004220.SGD","00867"],"gpt_icon":0},{"id":"2571528383","title":"复星医药徐汇宜山路项目12.56亿元易主！","url":"https://stock-news.laohu8.com/highlight/detail?id=2571528383","media":"AEGISTAR","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571528383?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 20:56","pubTimestamp":1759150606,"startTime":"0","endTime":"0","summary":"老牌药企复星医药最近干了件大事——把位于上海徐汇区宜山路的医药研发基地挂牌出售了。黄金地块的诱惑，宜山路这块地可是徐汇区的\"钻石地段\"，紧邻漕河泾开发区，地铁9号线、12号线交汇处。复星医药2015年拿地时价格还不算离谱，但现在周边商业配套成熟，地价早就翻了几番。复星轻装上阵的战略考量，这两年明显在收缩战线，从文旅到地产都在瘦身。这事儿说到底就是各取所需：复星套现过冬，新主抄底进场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930001627a6a6aa1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930001627a6a6aa1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","02196","BK1191"],"gpt_icon":0},{"id":"2571895983","title":"昊海生物科技(06826)：楼国梁已累计减持公司股份149.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2571895983","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571895983?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 17:44","pubTimestamp":1759139057,"startTime":"0","endTime":"0","summary":"公司于2025年9月29日收到楼国梁先生出具的《关于股份减持结果的告知函》，其本次股份减持计划时间区间届满。截至2025年9月29日，楼国梁先生已通过集中竞价的方式累计减持公司股份149.14万股，占目前公司总股本2.33亿股的0.6413%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"gpt_icon":0},{"id":"2571330077","title":"每日卖空追踪 | 复星医药 09月29日卖空量成交12.65万股，卖空比例为2.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571330077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571330077?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 16:30","pubTimestamp":1759134630,"startTime":"0","endTime":"0","summary":"复星医药北京时间09月29日，涨1.71%，卖空量成交12.65万股，较上一交易日减少60.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163329a6a5d029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163329a6a5d029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","BK1191","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":141,"code":"91000000","status":"200"}]}}